The Raja Permaisuri Bainun Hospital Ipoh (HRPB) Clinical Research Centre (CRC) has been selected as one of the centres to conduct the COVID-19 vaccine third phase clinical studies under the supervision of the Clinical Research Institute.

This study is a collaboration between the Institute of Medical Biology Chinese Academy of Medical Sciences (IMBCAMS) and the Ministry of Health Malaysia (MOH). The study will involve 3,000 healthy volunteers throughout Malaysia to assess the safety and efficacy of the COVID-19 vaccine. A total of 200 participants will be recruited by the HRPB CRC. The study is expected to begin in January - March 2021.